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Objective. To report a case of diabetic muscle infarction (DMI), a rare complication of long-standing poorly controlled diabetes
mellitus. Methods. We describe a case of a 45-year-old male with an approximately 8-year history of poorly controlled type 2
diabetes mellitus with multiple microvascular complications who presented with the sudden onset of left thigh pain and swelling.
He had a swollen left thigh and a CK of 1670U/L. He was initially treated with intravenous antibiotics for a presumptive diagnosis
of pyomyositis or necrotizing fasciitis with no improvement. A diagnosis of diabetic muscle infarction was considered. Results. An
MRI of the thigh demonstrated diﬀuse edema in the anterior compartment. A muscle biopsy demonstrated coagulation necrosis
in skeletal muscle and inflammation and infarction in the walls of small blood vessels. These studies confirmed the final diagnosis
of DMI. He was treated with supportive care and gradually improved. Conclusion. DMI is a rare complication of diabetes that is
often mistaken for infections such as pyomyositis and necrotizing fasciitis or thrombophlebitis. Treatment is supportive. Although
the short-term prognosis is good in these patients, the long-term prognosis is poor.
1. Introduction
Spontaneous diabetic muscle infarction (DMI) is a rare
complication associated with uncontrolled diabetes mellitus
(DM). These patients typically present with a palpable
mass in an extremity, with localized pain and swelling. The
patients usually have coexisting microvascular complications
such as neuropathy, nephropathy, and retinopathy. Failure to
recognize the condition often leads to unnecessary invasive
procedures to establish a diagnosis. We describe a case of
DMI and discuss its clinical features, pathogenesis, diagnosis,
management, and prognosis.
2. Case Report
A 45-year-old African-American male with uncontrolled
type 2 diabetes mellitus was admitted to a community hospi-
tal with sudden onset of pain in his left thigh associated with
swelling. His past medical history included stage IV chronic
kidney disease, background retinopathy, peripheral vascular
disease requiring below the knee amputation of his left
lower extremity, severe peripheral neuropathy, uncontrolled
hypertension, and a prior history of tobacco use.
He denied any trauma or administering insulin injections
into his left thigh. He was noted to have an elevated creatine
kinase of 1670U/L (reference range, 32–294) and found to be
severely anemic requiring transfusion with 4 units of packed
red blood cells (PRBC). CKMB and troponin levels were
0.31 ng/mL (reference range, 0–5 ng/mL) and 0.02 ng/mL
(reference range, 0–012 ng/mL), respectively. EKG demon-
strated normal sinus rhythm with no ST-T changes. In
addition, he was treated with intravenous antibiotics at
presentation due to concerns for necrotizing fasciitis with
no improvement in his condition. An MRI of the left thigh
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Figure 1: T2-weighted magnetic resonance image: transverse view
of the left thigh: demonstrating diﬀuse edema in the anterior
compartment and subcutaneous edema in the anterior and lateral
aspects of the thigh.
without contrast was obtained that demonstrated diﬀuse
edema in the anterior compartment and subcutaneous
edema in the anterior and lateral aspects of the thigh
(Figure 1). Due to persistent symptoms, a biopsy of the left
thigh muscle was done. In addition, he was also evaluated
by a rheumatologist for a possible underlying autoimmune
process, which was subsequently ruled out. Approximately
14 days after his initial presentation, he was transferred to
our tertiary care medical center. On physical examination
after transfer, the left thigh was swollen and firm, extending
anteromedially to the lateral aspect of the thigh at the surgical
biopsy site superiorly and to the left inguinal ligament. He
had an incision measuring approximately 5 cm on the lateral
aspect of his left thigh that was packed with gauze. The inci-
sion site was tender to palpation. Monofilament examination
of his right lower extremity was compatible with diabetic
polyneuropathy with loss of protective sensation.
Laboratory studies at our hospital demonstrated a white
blood cell count of 13 k/uL (reference range, 4.5–11.0),
hemoglobin 10.6 g/dL (reference range, 13.0–18.0), hema-
tocrit 31% (reference range, 40–52), serum creatinine of
4mg/dL(reference range, 0.60–1.20), ESR 120mm/h (ref-
erence range, 0–12), and a CRP was 213mg/L (reference
range, <2.6). An A1C of 7.1% (reference range, 4.3–5.7)
was obtained after he was transfused 4 units of PRBC. An
antinuclear antibody screen was within normal limits. A
left lower extremity venous doppler revealed no evidence
of deep venous thrombosis. Biopsy findings of the skin
and subcutaneous tissue (reviewed independently by a
surgical pathologist at our institution) demonstrated acute
to subacute inflammation in the deep subcutaneous tissue
and fascia. Biopsy of the left thigh muscle demonstrated
coagulation necrosis with acute to subacute inflammation
and areas of early fibrosis in skeletal muscle (Figure 2).
Thrombotic material was seen in a few small blood vessels
and the walls of some of the blood vessels were acutely
inflamed (Figure 3).
The swelling and hardness gradually improved over the
next week during which the patient rested his leg and
was managed symptomatically for his pain. A week after
Figure 2: Histologic appearance of muscle tissue demonstrating
coagulation necrosis in skeletal muscle (Hematoxylin-eosin stain:
original magnification 200X).
Figure 3: Histologic appearance of muscle tissue demonstrating
small blood vessels in area of infarction with inflammation in the
walls and thrombotic material in the lumen (Hematoxylin-eosin
stain: original magnification 400X).
admission at our institution he requested to be discharged.
At the time of discharge his symptoms had improved but had
not resolved completely. Since then he was lost to followup.
3. Discussion
DMI is a rare complication usually reported in association
with long-standing poorly controlled diabetes mellitus.
Although first described in 1965, less than 200 cases have
been reported in the literature [1]. This paucity of cases
may be a result of the unfamiliarity of this rare condition
to clinicians. The patient described in this case report had
uncontrolled diabetes mellitus with associated microvascular
and macrovascular complications which have been reported
previously as risk factors for developing DMI [2]. The
average age of presentation for DMI has been reported to
be 40 years with a range between 13 and 81 years [3, 4].
Patients with DMI usually present with acute pain with
swelling (and occasionally a palpable mass) in an extremity
that persists at rest and worsens with exercise, without any
prior history of trauma [5]. In addition to the thigh muscles,
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Table 1: Diﬀerential diagnosis of focal extremity pain in patients
with diabetes mellitus.
(i) Inflammatory: focal myositis, polymyositis
(ii) Vascular: hemorrhage, diabetic muscle infarction, arterial
occlusion, thrombophlebitis, lymphedema
(iii) Infectious: pyomyositis, osteomyelitis, cellulitis, necrotizing
fasciitis
(iv) Trauma: muscle tear, ruptured cyst
(v) Neoplastic: benign tumors (lipomas, chondromas, and
fibromas), sarcomas (liposarcoma, fibrosarcoma)
(vi) Miscellaneous: diabetic amyotrophy, and calciphylaxis
DMI has also been reported in calf muscles, upper extremity,
and abdominal wall muscles [6–8]. Joshi et al. reviewed the
clinical course, laboratory findings, and the pathophysiology
of DMI in patients on hemodialysis. They noted that in
this group of patients DMI was more common in men
whereas in most reports DMI is more common in women
[7].
Laboratory studies generally demonstrate an elevated
ESR and normal or mildly elevated WBC counts. Measure-
ments of creatine kinase (CK, a marker of muscle necrosis)
may be normal or elevated depending on timing of blood
sampling and amount of muscle involved [7]. In most cases
where a normal CK has been reported, there was a delay
of several days to weeks after the onset of symptoms before
the initial CK level was obtained. A normal CK level thus
does not preclude the diagnosis of DMI and is hence not
a reliable marker in DMI. Obtaining a CK level within few
days after the acute infarct will more likely result in elevated
levels. Patient described in this case report had a CKMB level
within normal limits. However, his troponin was found to
be mildly elevated which is likely secondary to his chronic
kidney disease.
The diﬀerential diagnosis for focal extremity pain in
patients with DM is shown in Table 1. An MRI is often
helpful but may not distinguish all of these conditions
except amyotrophy, in which case it is essentially normal.
Patients presenting with pyomyositis typically have a history
of trauma with a staph infection, and an acute presentation.
Unlike DMI, they also have an elevated WBC and ESR,
normal CK, a purulent aspirate with positive cultures and
contiguous areas of involvement on an MRI. Necrotizing
fasciitis is a fulminate life-threatening infection, more com-
mon in patients with diabetes, that requires immediate sur-
gical intervention if suspected. Patients with tumors usually
have a nontender mass with pain developing insidiously.
Since patients with diabetic muscle infarction usually
have a stereotyped presentation, it is imperative to recognize
this uncommon condition. Venous Doppler and venography
are used with the aim of excluding venous thrombosis.
MRI is the diagnostic test of choice for diabetic muscle
infarction. Due to its superior soft tissue contrast, it is
the most sensitive imaging study in detecting DMI. MRI
findings demonstrate diﬀuse edema and swelling of multiple
thigh or calf muscles, often in more than one compartment
[6].
Muscle biopsy can firmly establish the diagnosis. How-
ever, open excisional surgical biopsy is not recommended
since it may lead to an increase in healing time due to
postoperative complications such as hematoma, seroma,
and delayed wound healing [3]. Needle biopsy may be an
option in patients with atypical clinical presentation or
in whom appropriate treatment measures fail [8]. Mus-
cle biopsy generally demonstrates muscle fiber necrosis,
inflammatory cell infiltrate, and microvascular abnormali-
ties.
The underlying pathophysiology of DMI remains incom-
pletely understood although stenosis of intramuscular vessels
leading to muscle infarction has been proposed to play a role
[9]. Diabetic microangiopathy, in association with hypoxia-
reperfusion injury, has also been implicated resulting in
severe inflammatory response, edema, and reperfusion [10].
In addition, several other reports have implicated a hyper-
coagulable state associated with antithrombin II deficiency,
increased factor VII, hyperhomocysteinemia, presence of
antiphospholipid antibodies, and decreased prostacyclin and
tissue plasminogen activator levels as a possible cause of
diabetic muscle infarction [11, 12].
The mainstay of treatment for DMI involves early
recognition, bed rest, analgesics, and aggressive control of
DM. Other modalities suggested to be beneficial include
low-dose aspirin, pentoxiphylline, nifedipine, dipyridamole,
nonsteroidal agents, and anticoagulants however; there are
no randomized control trials to support the use of these
agents [13]. Vigorous physical therapy should be avoided
since it may lead to an exacerbation [5]. Patients usually
recover spontaneously over a period of weeks to months
of bedrest although the recurrence rate in the same or the
contralateral extremity is approximately 40% in all treatment
groups [13, 14].
In general the short-term prognosis is reported to be be-
nign, however long-term outcome is discouraging. Patients
have been reported to have died within two years after being
diagnosed with DMI mostly from the vascular complications
associated with diabetes mellitus [14]. In one study the
prognosis of DMI in patients with DM is reported as
being similar to that after myocardial infarction, with both
conditions invariably involving significant vascular injury
[15].
4. Conclusion
Diabetic muscle infarction is an extremely rare but sig-
nificant complication of diabetes mellitus with an overall
poor long-term outcome. With the increasing prevalence of
diabetes mellitus in our society, the incidence of diabetes
muscle infarction can be expected to increase. Clinicians
need to have a high index of suspicion to recognize this rare
condition. With a good clinical history and timely imaging
studies, the diagnosis of this rare condition can be made with
confidence leading to appropriate intervention and better
outcomes.
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